Monitoring and avoiding drug and chemical teratogenicity.
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control*; D000818:Animals; D003376:Counseling; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005069:Evaluation Studies as Topic; D005260:Female; D000882:Haplorhini; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy / Q000187:drug effects; D011358:Product Surveillance, Postmarketing; D011446:Prospective Studies; D011817:Rabbits; D051381:Rats; D012189:Retrospective Studies; D012306:Risk